Delivery Order SPE2DB25D3020-SPE2DB25FWHFE

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,640.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Orencia Clickject 125 mg/ml, a pharmaceutical product. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $17,659.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Orencia Clickject 125 mg/ml, a medication used to treat autoimmune disorders. The contract has a firm fixed price pricing type and an ultimate completion date of April 11, 2025. This award is not associated with a set-aside program and is...
This federal contract award, valued at $6,923.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Orencia Clickject 125 mg/ml, a medication, with a completion date of March 27, 2025. This contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $10,124.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orencia 125 mg/ml syringes, a specialty medication, with a completion date of May 3, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,287.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orencia 125 mg/ml syringes, a specialty medication used in the treatment of various medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,711.89, is for the delivery of Orencia 125 mg/ml syringes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $30,761.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Orencia Clickject 125 mg/ml, with a performance period through April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award, valued at $12,111.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Orencia 125 mg/mL syringes, a specialty medication. The contract has a firm fixed price and an ultimate completion date of January 13, 2025. AmerisourceBergen holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply Orencia 125 mg/ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical program. The contract, worth $13,171.38, is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of...
This federal contract award, valued at $15,972.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Orencia 125 mg/ml syringes, a specialty medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB25D3020
    Indefinite Delivery Contract
  • SPE2DB25D3020-SPE2DB25FWHFE
    Delivery Order

This federal contract award, valued at $10,482.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orencia 125 mg/ml syringes, a medication used to treat autoimmune disorders. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. It is not designated as a set-aside contract, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/29/25, 10:05 AM